• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cutoff level to detect heterozygous alpha 1 antitrypsin deficiency in Turkish population.用于检测土耳其人群中杂合子型α1-抗胰蛋白酶缺乏症的截断值。
J Clin Lab Anal. 2011;25(4):296-9. doi: 10.1002/jcla.20472.
2
α-1 Antitrypsin Genotype-Phenotype Discrepancy in a 42-Year-Old Man Who Carries the Null-Allele.一名携带无效等位基因的42岁男性的α-1抗胰蛋白酶基因型-表型差异
Lab Med. 2020 May 6;51(3):301-305. doi: 10.1093/labmed/lmz059.
3
Null: A novel α-antitrypsin allele with in cis variants Glu366Lys and Ile100Asn.Null:一种新型α-1 抗胰蛋白酶等位基因,具有顺式变异 Glu366Lys 和 Ile100Asn。
Clin Biochem. 2020 May;79:23-27. doi: 10.1016/j.clinbiochem.2020.02.013. Epub 2020 Feb 19.
4
Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls.结直肠癌患者血清α-1抗胰蛋白酶浓度显著高于健康对照组。
BMC Cancer. 2014 May 21;14:355. doi: 10.1186/1471-2407-14-355.
5
European screening for alpha -antitrypsin deficiency in subjects with lung disease.欧洲对肺病患者进行α-抗胰蛋白酶缺乏症筛查。
Clin Respir J. 2017 Jan;11(1):90-97. doi: 10.1111/crj.12310. Epub 2015 Jun 11.
6
Genotypes and serum concentrations of human alpha-1-antitrypsin "P" protein variants in a clinical population.临床人群中人类α-1-抗胰蛋白酶“P”蛋白变体的基因型和血清浓度
J Clin Pathol. 2007 Oct;60(10):1124-8. doi: 10.1136/jcp.2006.042762.
7
Prevalence of Alpha-1 Antitrypsin Deficiency Alleles in a Lithuanian Cohort of Wheezing Small Children.喘息性细支气管炎患儿的α-1 抗胰蛋白酶缺乏等位基因在立陶宛队列中的流行率。
Adv Respir Med. 2024 Aug 5;92(4):291-299. doi: 10.3390/arm92040028.
8
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.欧洲成年人杂合子或纯合子 AAT Pi∗Z 变异(Pi∗MZ 与 Pi∗ZZ 基因型)与非携带者的肝脏表型。
Gastroenterology. 2020 Aug;159(2):534-548.e11. doi: 10.1053/j.gastro.2020.04.058. Epub 2020 May 4.
9
The prevalence of alpha(1)-antitrypsin deficiency in a representative population sample from Poland.波兰代表性人群样本中α1-抗胰蛋白酶缺乏症的患病率。
Respir Med. 2007 Dec;101(12):2520-5. doi: 10.1016/j.rmed.2007.06.032. Epub 2007 Aug 10.
10
[Diagnosis of alpha-1 antitrypsin deficiency: limitations of rapid diagnostic laboratory tests].[α-1抗胰蛋白酶缺乏症的诊断:快速诊断实验室检测的局限性]
Arch Bronconeumol. 2011 Aug;47(8):415-7. doi: 10.1016/j.arbres.2011.02.005. Epub 2011 Apr 5.

引用本文的文献

1
Frequency of alpha-1 antitrypsin deficiency and unexpected results in COPD patients in Turkey; rare variants are common.在土耳其,α-1 抗胰蛋白酶缺乏症在 COPD 患者中的频率和意外结果;罕见变异很常见。
Turk J Med Sci. 2022 Oct;52(5):1478-1485. doi: 10.55730/1300-0144.5486. Epub 2022 Oct 19.
2
Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.α-1抗胰蛋白酶缺乏症:提高认识与改善诊断
Ther Adv Respir Dis. 2016 Feb;10(1):72-84. doi: 10.1177/1753465815602162. Epub 2015 Sep 4.
3
Alpha-1 antitrypsin deficiency in Iranian patients with chronic obstructive pulmonary disease.伊朗慢性阻塞性肺疾病患者的α-1抗胰蛋白酶缺乏症
Iran Red Crescent Med J. 2013 Nov;15(11):e7508. doi: 10.5812/ircmj.7508. Epub 2013 Nov 5.

本文引用的文献

1
Prevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control study.α1-抗胰蛋白酶(SERPINA1)基因启动子区遗传多态性在慢性肝病中的研究:病例对照研究。
BMC Gastroenterol. 2010 Feb 20;10:22. doi: 10.1186/1471-230X-10-22.
2
Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America.加勒比地区以及北美洲、中美洲和南美洲中PI*S和PI*Zα-1抗胰蛋白酶缺乏症等位基因流行率的估计。
Monaldi Arch Chest Dis. 2009 Sep;71(3):96-105. doi: 10.4081/monaldi.2009.354.
3
The cut-off value of 100 mg/dl is insufficient to detect heterozygous alpha-1 antitrypsin-deficient liver disease patients.100毫克/分升的临界值不足以检测出杂合子α-1抗胰蛋白酶缺乏性肝病患者。
Liver Int. 2010 Mar;30(3):491-2. doi: 10.1111/j.1478-3231.2009.02179.x. Epub 2009 Nov 30.
4
Clinical practice. Alpha1-antitrypsin deficiency.临床实践。α1-抗胰蛋白酶缺乏症。
N Engl J Med. 2009 Jun 25;360(26):2749-57. doi: 10.1056/NEJMcp0900449.
5
Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review.杂合子α-1抗胰蛋白酶缺乏作为慢性肝病发展的一个辅助因素:综述
Neth J Med. 2007 May;65(5):160-6.
6
Environmental, occupational, and genetic risk factors for alpha-1 antitrypsin deficiency.α-1抗胰蛋白酶缺乏症的环境、职业和遗传风险因素。
Environ Health Perspect. 2003 Nov;111(14):1749-52. doi: 10.1289/ehp.6325.
7
Serum levels of alpha1-antitrypsin predict phenotypic expression of the alpha1-antitrypsin gene.血清α1-抗胰蛋白酶水平可预测α1-抗胰蛋白酶基因的表型表达。
Dig Dis Sci. 2003 Sep;48(9):1793-6. doi: 10.1023/a:1025411515683.
8
Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.α1抗胰蛋白酶缺乏症的全球种族和民族分布:已发表的遗传流行病学调查分析总结
Chest. 2002 Nov;122(5):1818-29. doi: 10.1378/chest.122.5.1818.
9
Alpha1-antitrypsin deficiency--a model for conformational diseases.α1-抗胰蛋白酶缺乏症——一种构象性疾病的模型。
N Engl J Med. 2002 Jan 3;346(1):45-53. doi: 10.1056/NEJMra010772.
10
Chronic liver disease in heterozygous alpha1-antitrypsin deficiency PiZ.杂合子α1-抗胰蛋白酶缺乏症PiZ中的慢性肝病
J Hepatol. 2000 Dec;33(6):883-92. doi: 10.1016/s0168-8278(00)80119-1.

用于检测土耳其人群中杂合子型α1-抗胰蛋白酶缺乏症的截断值。

Cutoff level to detect heterozygous alpha 1 antitrypsin deficiency in Turkish population.

机构信息

Department of Internal Medicine, Division of Hepatology, Hacettepe University Medical Faculty, Ankara, Turkey.

出版信息

J Clin Lab Anal. 2011;25(4):296-9. doi: 10.1002/jcla.20472.

DOI:10.1002/jcla.20472
PMID:21786332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6647731/
Abstract

BACKGROUND

Alpha 1 antitrypsin (AT) deficiency is a hereditary disorder leading to the defective defence system against neutrophil elastasis in lung and accumulation of insoluble heterodimer AT molecules in hepatocytes. Knowledge of the prevalence of AT deficiency in each country is important to organize the public health policy. The aim of this study is to determine the prevalence of AT deficiency in Turkish population and to define the cutoff value of AT level in serum to detect heterozygous AT deficient subjects.

MATERIALS AND METHODS

Serum samples from 1,203 healthy blood donors were used, attending the Blood Bank of Hacettepe Medical Faculty. Isoelectric focusing method for determining PIM, PIS, and PIZ alleles and rate immune nephelometry for measuring the level of AT in serum were used.

RESULTS

Out of 1,203 healthy blood donors enrolled, 1,164 (%96.8) had normal variant PI MM allelee, 9 (%0.7) PI MZ, 7 (%0.6) PI MS, 6 (%0.5) MF, and 17 (%1.4) PI M? (unidentified variants with existing standards). Most individuals (89.6%) with low AT level (cutoff <100 mg/dl) in serum were positive for PI MM allele. The cutoff value to investigate PI MZ was 100.5 mg/dl, which had PPV and NPV of 5.0 and 99.9%, respectively. AT deficiency is a rare hereditary disorder in asymptomatic healthy Turkish blood donors. Although the cutoff value of 100.5 mg/dl for AT level in serum was able to detect heterozygous AT deficiency in the healthy population, this finding should be conformed to case-control studies.

摘要

背景

α1 抗胰蛋白酶(AT)缺乏症是一种遗传性疾病,导致肺中中性粒细胞弹性蛋白酶防御系统缺陷和不溶性杂合二聚体 AT 分子在肝细胞中积聚。了解每个国家 AT 缺乏症的患病率对于组织公共卫生政策很重要。本研究旨在确定土耳其人群中 AT 缺乏症的患病率,并确定血清中 AT 水平的截止值以检测杂合子 AT 缺乏的受试者。

材料和方法

使用来自参加哈塞特佩医科大学血库的 1203 名健康献血者的血清样本。使用等电聚焦法测定 PIM、PIS 和 PIZ 等位基因,速率免疫比浊法测定血清 AT 水平。

结果

在纳入的 1203 名健康献血者中,1164 名(96.8%)具有正常变异 PI MM 等位基因,9 名(0.7%)PI MZ,7 名(0.6%)PI MS,6 名(0.5%)MF 和 17 名(1.4%)PI M?(现有标准下的未识别变异体)。大多数血清中 AT 水平较低(<100mg/dl 的截止值)的个体(89.6%)为 PI MM 等位基因阳性。PI MZ 的检测截止值为 100.5mg/dl,其阳性预测值和阴性预测值分别为 5.0%和 99.9%。AT 缺乏症是无症状健康土耳其献血者中罕见的遗传性疾病。虽然血清中 AT 水平的 100.5mg/dl 截止值可以检测健康人群中的杂合子 AT 缺乏症,但这一发现应与病例对照研究相吻合。